NASDAQ: GCTK
Glucotrack Inc Stock Ownership - Who owns Glucotrack?

Insider buying vs selling

Have Glucotrack Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John BallantyneDirector2024-11-14132,036$31.00
$4.09MBuy
Erin Catherine CarterDirector2024-11-142,078$31.20
$64.83kBuy
Paul GoodeChief Executive Officer2024-11-14796$31.20
$24.84kBuy
A. Ballantyne Revocable Living Trust Dated 08 John10% Owner2024-11-14132,036$31.00
$4.09MBuy
Luis MalaveDirector2024-11-146,886$31.20
$214.84kBuy

1 of 1

GCTK insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GCTK insiders and whales buy or sell their stock.

GCTK Shareholders

What type of owners hold Glucotrack Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
John Ballantyne789.26%3,767,750$22.04MInsider
Drew Sycoff618.22%2,951,257$17.26MInsider
Alerus Financial Na62.84%300,000$1.76MInstitution
Luis Malave30.08%143,617$840.16kInsider
Virtu Financial LLC10.72%51,191$299.47kInstitution
A. Ballantyne Revocable Living Trust Dated 08 John10.68%51,002$298.36kInsider
Erin Catherine Carter9.56%45,632$266.95kInsider
Hrt Financial LP7.37%35,196$205.90kInstitution
Paul Goode3.98%18,989$111.09kInsider
Xtx Topco Ltd2.90%13,831$80.91kInstitution

1 of 2

GCTK vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GCTK5.42%94.58%Net Buying
STSS81.79%18.21%Net Buying
EKSO12.26%87.74%
LUCY0.17%99.83%Net Buying
POAI0.08%99.92%

Glucotrack Stock Ownership FAQ

Who owns Glucotrack?

Glucotrack (NASDAQ: GCTK) is owned by 83.85% institutional shareholders, 1,463.55% Glucotrack insiders, and 0.00% retail investors. John Ballantyne is the largest individual Glucotrack shareholder, owning 3.77M shares representing 789.26% of the company. John Ballantyne's Glucotrack shares are currently valued at $21.55M.

If you're new to stock investing, here's how to buy Glucotrack stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.